Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Dear Doctor Letter (Rote-Hand-Brief) on Eligard® (leuprorelin acetate): medication errors due to overtightening of the safety needle
2017.12.14
Active substance: leuprorelin acetate
The company Astellas is circulating information on medication errors reported in connection with leakage of the medicinal product from the syringe.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN